Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

PROK

ProKidney Corp

Jun 18 • 04:00PM ET

2.68

Dollar change -0.24
Percentage change -8.22	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN VTWO SCHA IWO VTWV IWV RSSL

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.57	Insider Own	63.96%	Shs Outstand	59.88M	Perf Week	10.74%
Market Cap	171.31M	Forward P/E	-	EPS next Y	-0.55	Insider Trans	124.33%	Shs Float	23.04M	Perf Month	-33.91%
Income	-35.30M	PEG	-	EPS next Q	-0.28	Inst Own	51.33%	Short Float	44.78%	Perf Quarter	95.62%
Sales	0.00M	P/S	-	EPS this Y	-46.21%	Inst Trans	2.15%	Short Ratio	10.81	Perf Half Y	50.56%
Book/sh	-17.79	P/B	-	EPS next Y	33.99%	ROA	-8.00%	Short Interest	10.32M	Perf Year	-74.22%
Cash/sh	5.15	P/C	0.52	EPS next 5Y	-	ROE	-	52W Range	1.12 - 13.51	Perf YTD	50.56%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-80.16%	Beta	1.34
Dividend TTM	-	Quick Ratio	17.62	Sales past 5Y	0.00%	Gross Margin	-	52W Low	139.29%	ATR (14)	0.52
Dividend Ex-Date	-	Current Ratio	17.62	EPS Y/Y TTM	-8.15%	Oper. Margin	0.00%	RSI (14)	44.49	Volatility	23.60% 18.52%
Employees	163	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.86	Target Price	4.83
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	0.83%	Payout	-	Rel Volume	0.42	Prev Close	2.92
Sales Surprise	-	EPS Surprise	45.41%	Sales Q/Q	-	Earnings	May 10 BMO	Avg Volume	954.53K	Price	2.68
SMA20	-20.23%	SMA50	-5.75%	SMA200	5.42%	Trades		Volume	404,010	Change	-8.22%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-07-24	Resumed	Morgan Stanley	Equal-Weight	$3
Jan-02-24	Downgrade	BofA Securities	Buy → Neutral
Jul-25-23	Initiated	BTIG Research	Buy	$16
Dec-21-22	Initiated	Jefferies	Buy	$15
Nov-10-22	Initiated	Morgan Stanley	Equal-Weight	$13
Oct-18-22	Initiated	UBS	Buy	$18
Oct-14-22	Initiated	Citigroup	Buy	$16
Sep-23-22	Initiated	BofA Securities	Buy	$14
Sep-02-22	Initiated	Evercore ISI	Outperform

Jun-17-24 07:00AM	ProKidney Announces the Closing of $140 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters' Option (GlobeNewswire) +6.96%
Jun-11-24 09:35PM	ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering (GlobeNewswire) -19.87% +23.55%
07:40AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jun-10-24 04:15PM	ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering (GlobeNewswire) -5.33%
07:32AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
06:30AM	ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates (GlobeNewswire)
May-29-24 07:00AM	ProKidney to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) +6.74%
May-21-24 07:00AM	ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024 (GlobeNewswire)
May-10-24 03:43PM	ProKidney Corp Reports First Quarter 2024 Financial Results (GuruFocus.com) +7.66%
01:54PM	PROK Stock Earnings: ProKidney Beats EPS for Q1 2024 (InvestorPlace)
07:48AM	ProKidney Q1 Loss Unchanged From Year Earlier (MT Newswires)
07:00AM	ProKidney Reports Business Updates and First Quarter 2024 Financial Results (GlobeNewswire)
Mar-25-24 06:05AM	ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations (GlobeNewswire)
Mar-21-24 07:49PM	ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire) -6.16%
Feb-29-24 04:05PM	ProKidney to Participate in Jefferies Biotech on the Bay Summit (GlobeNewswire)
Dec-29-23 08:22AM	Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years (Insider Monkey)
Dec-13-23 09:55AM	Here's Why ProKidney Corp. (PROK) Is a Great 'Buy the Bottom' Stock Now (Zacks) +9.60%
Nov-30-23 06:05AM	ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer (GlobeNewswire) -10.16%
Nov-24-23 06:40AM	7 Penny Stocks With Low Floats and High Short Interest (InvestorPlace)
Nov-21-23 06:05AM	ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference (GlobeNewswire) +5.68%
Nov-17-23 01:38PM	ProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-16-23 09:35AM	After Plunging -37.39% in 4 Weeks, Here's Why the Trend Might Reverse for ProKidney Corp. (PROK) (Zacks) -11.51%
Nov-14-23 07:04AM	ProKidney Corp (PROK) Reports Q3 Financial Results: Focus on Chronic Kidney Disease Trials (GuruFocus.com) -5.00%
06:05AM	ProKidney Reports Third Quarter Financial Results (GlobeNewswire)
Nov-13-23 05:02PM	ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT ) for Diabetic CKD and Provides Corporate Updates (GlobeNewswire)
Oct-30-23 04:12PM	ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023 (GlobeNewswire) +12.29%
Oct-17-23 09:35AM	ProKidney Corp. (PROK) Loses -54.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) -7.93%
Oct-16-23 02:50PM	Is Chamath Palihapitiya Giving Up on ProKidney (PROK) Stock? (InvestorPlace)
Oct-12-23 03:05PM	Why Shares of ProKidney Were Dropping Thursday (Motley Fool) -31.45%
Sep-06-23 12:14PM	ProKidney confirms it will expand HQ complex, add 50 jobs in Winston-Salem (American City Business Journals)
Sep-05-23 06:05AM	ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-31-23 10:33AM	3 Biotech Stocks Due for a Massive Short Squeeze (InvestorPlace)
Aug-29-23 01:16PM	ProKidney confirmed as company seeking incentives to expand in Forsyth County (American City Business Journals)
Aug-11-23 02:21PM	ProKidney reports $38.8 million loss in Q2 FY2023 as it advances clinical trials and prepares for Greensboro manufacturing expansion (American City Business Journals)
Aug-10-23 04:10PM	ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights (GlobeNewswire)
Jul-18-23 06:05AM	ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC (GlobeNewswire)
Jul-17-23 06:05AM	ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization (GlobeNewswire) +6.65%
Jun-13-23 12:05PM	ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC (GlobeNewswire)
Jun-01-23 04:05PM	ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference (GlobeNewswire) -7.66%
May-11-23 04:01PM	ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights (GlobeNewswire)
May-04-23 06:05AM	ProKidney to Present at the BofA Securities Health Care Conference 2023 (GlobeNewswire)
Apr-25-23 02:00PM	We're Interested To See How ProKidney (NASDAQ:PROK) Uses Its Cash Hoard To Grow (Simply Wall St.) -8.73%
Mar-28-23 04:12PM	ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights (GlobeNewswire) -7.39%
Mar-03-23 06:05AM	ProKidney to Participate in TD Cowens 43rd Annual Health Care Conference (GlobeNewswire)
Jan-11-23 07:48AM	ProKidneys stock jumps 29% (MarketWatch)
Jan-10-23 04:05PM	ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease (GlobeNewswire) +9.57%
Dec-27-22 11:05AM	Chamath Palihapitiya Stocks: 10 Stocks Picked in the Last 10 Years (Insider Monkey) -5.82%
08:46AM	A Look At The Intrinsic Value Of ProKidney Corp. (NASDAQ:PROK) (Simply Wall St.)
Dec-22-22 06:05AM	ProKidney to Present at the J.P. Morgan 41st Annual Healthcare Conference (GlobeNewswire)
Nov-16-22 11:22AM	ProKidney (NASDAQ:PROK) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Nov-14-22 06:05AM	ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Nov-11-22 04:05PM	ProKidney to Participate in Upcoming Investor Conferences (GlobeNewswire) +6.85%
Nov-03-22 06:05AM	ProKidney Receives Allowance from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for proact 1 (REGEN-006) and EMA Scientific Advice on Phase 3 Protocols of REACT for Diabetic Chronic Kidney Disease (GlobeNewswire)
Oct-14-22 12:00PM	ProKidney Announces Multiple Abstracts Selected for Presentation at the American Society of Nephrologys Kidney Week 2022 (GlobeNewswire)
Sep-23-22 06:15AM	ProKidney to Present at the Jefferies Cell and Genetic Medicine Summit (GlobeNewswire)
Sep-08-22 06:05AM	ProKidney to Present at the Morgan Stanley 20th Annual Global Healthcare Conference (GlobeNewswire)
Aug-31-22 06:05AM	ProKidney Appoints Glenn Schulman, PharmD, MPH, as Senior Vice President of Investor Relations (GlobeNewswire) +12.28%
Aug-11-22 05:30PM	ProKidney Corp. Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) +7.55%
10:01AM	ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox (GlobeNewswire)
Jul-20-22 08:00AM	ProKidney Appoints Kerry Cooper, M.D., as Senior Vice President of Medical Affairs (GlobeNewswire)

ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Legorreta Pablo G.	Director	Jun 13 '24	Buy	2.42	22,617,909	54,735,340	22,617,909	Jun 14 04:05 PM
Weber Darin J.	Chief Regulatory Officer	May 20 '24	Sale	4.08	17,238	70,386	137,956	May 22 07:22 AM
Weber Darin J.	SVP of Regulatory Development	Apr 22 '24	Sale	2.51	16,438	41,315	155,194	Apr 23 04:05 PM
Weber Darin J.	SVP of Regulatory Development	Apr 18 '24	Sale	2.54	800	2,028	171,632	Apr 23 04:05 PM
Weber Darin J.	SVP of Regulatory Development	Apr 16 '24	Sale	2.50	17,238	43,095	172,432	Apr 17 06:57 PM
Weber Darin J.	SVP of Regulatory Development	Apr 12 '24	Sale	1.73	84,103	145,498	189,670	Apr 16 04:54 PM
Weber Darin J.	SVP of Regulatory Development	Apr 01 '24	Sale	1.69	300	507	273,773	Apr 16 04:54 PM
Control Empresarial de Capital	Add'l Rep. Persons-see Ex.99-1	Mar 25 '24	Buy	1.43	30,000	42,954	63,295,645	May 16 08:22 PM
Control Empresarial de Capital	Add'l Rep. Persons-see Ex.99-1	Mar 22 '24	Buy	1.40	14,000	19,586	63,265,645	May 16 08:22 PM
Control Empresarial de Capital	Add'l Rep. Persons-see Ex.99-1	Mar 20 '24	Buy	1.40	33,000	46,111	63,251,645	May 16 08:22 PM
Control Empresarial de Capital	Add'l Rep. Persons-see Ex.99-1	Mar 14 '24	Buy	1.36	50,000	67,925	63,218,645	May 16 08:22 PM
Control Empresarial de Capital	Add'l Rep. Persons-see Ex.99-1	Mar 13 '24	Buy	1.50	50,000	75,090	63,168,645	May 16 08:22 PM
Palihapitiya Chamath	Former 10% Owner	Nov 19 '23	Sale	1.31	7,256,367	9,498,584	0	Nov 21 06:30 AM
Palihapitiya Chamath	10% Owner	Nov 17 '23	Sale	1.19	258,400	308,400	5,183,367	Nov 17 09:00 PM
Palihapitiya Chamath	10% Owner	Nov 16 '23	Sale	1.22	212,100	259,398	5,441,767	Nov 17 09:00 PM
Palihapitiya Chamath	10% Owner	Nov 15 '23	Sale	1.49	282,300	420,147	5,653,867	Nov 17 09:00 PM
Palihapitiya Chamath	10% Owner	Nov 14 '23	Sale	1.50	306,200	459,086	5,936,167	Nov 14 09:15 PM
Palihapitiya Chamath	10% Owner	Nov 13 '23	Sale	1.57	88,700	139,676	6,242,367	Nov 14 09:15 PM
Palihapitiya Chamath	10% Owner	Nov 10 '23	Sale	1.61	85,900	138,411	6,331,067	Nov 14 09:15 PM
Palihapitiya Chamath	10% Owner	Nov 09 '23	Sale	1.68	95,900	160,700	6,416,967	Nov 14 09:15 PM
Palihapitiya Chamath	10% Owner	Nov 08 '23	Sale	1.66	59,000	97,763	6,512,867	Nov 08 09:00 PM
Palihapitiya Chamath	10% Owner	Nov 07 '23	Sale	1.59	71,233	113,367	6,571,867	Nov 08 09:00 PM
Palihapitiya Chamath	10% Owner	Nov 06 '23	Sale	1.56	79,600	123,818	6,643,100	Nov 08 09:00 PM
Palihapitiya Chamath	10% Owner	Nov 03 '23	Sale	1.73	148,300	256,470	6,722,700	Nov 03 09:00 PM
Palihapitiya Chamath	10% Owner	Nov 02 '23	Sale	1.73	133,700	231,956	6,871,000	Nov 03 09:00 PM
Palihapitiya Chamath	10% Owner	Nov 01 '23	Sale	1.62	123,400	199,674	7,004,700	Nov 03 09:00 PM
Palihapitiya Chamath	10% Owner	Oct 31 '23	Sale	1.69	141,900	239,300	7,128,100	Oct 31 09:30 PM
Palihapitiya Chamath	10% Owner	Oct 30 '23	Sale	1.65	157,000	259,537	7,270,000	Oct 31 09:30 PM
Palihapitiya Chamath	10% Owner	Oct 27 '23	Sale	1.59	92,500	146,677	7,427,000	Oct 31 09:30 PM
Palihapitiya Chamath	10% Owner	Oct 26 '23	Sale	1.80	77,960	140,577	7,519,500	Oct 26 09:00 PM
Palihapitiya Chamath	10% Owner	Oct 25 '23	Sale	1.76	67,213	118,382	7,597,460	Oct 26 09:00 PM
Palihapitiya Chamath	10% Owner	Oct 24 '23	Sale	1.75	176,300	308,613	7,664,673	Oct 26 09:00 PM
Palihapitiya Chamath	10% Owner	Oct 23 '23	Sale	1.83	160,300	293,429	7,840,973	Oct 23 09:00 PM
Palihapitiya Chamath	10% Owner	Oct 20 '23	Sale	1.92	87,200	167,834	8,001,273	Oct 23 09:00 PM
Palihapitiya Chamath	10% Owner	Oct 19 '23	Sale	2.19	200,000	438,700	8,088,473	Oct 23 09:00 PM
Palihapitiya Chamath	10% Owner	Oct 18 '23	Sale	2.28	125,100	285,403	8,288,473	Oct 18 09:00 PM
Palihapitiya Chamath	10% Owner	Oct 17 '23	Sale	2.83	106,400	301,357	8,413,573	Oct 18 09:00 PM
Palihapitiya Chamath	10% Owner	Oct 16 '23	Sale	2.87	215,543	618,630	8,519,973	Oct 18 09:00 PM
Palihapitiya Chamath	10% Owner	Oct 13 '23	Sale	2.67	250,000	667,525	8,735,516	Oct 13 09:30 PM
Palihapitiya Chamath	10% Owner	Oct 12 '23	Sale	2.69	161,863	436,007	8,985,516	Oct 13 09:30 PM
Palihapitiya Chamath	10% Owner	Oct 11 '23	Sale	3.84	75,000	288,285	9,147,379	Oct 13 09:30 PM
Palihapitiya Chamath	10% Owner	Oct 10 '23	Sale	4.34	75,000	325,162	9,222,379	Oct 10 09:32 PM
Palihapitiya Chamath	10% Owner	Oct 09 '23	Sale	4.20	75,000	315,225	9,297,379	Oct 10 09:32 PM
Palihapitiya Chamath	10% Owner	Oct 06 '23	Sale	4.48	75,000	336,360	9,372,379	Oct 10 09:32 PM
Palihapitiya Chamath	10% Owner	Oct 05 '23	Sale	4.76	52,621	250,718	9,447,379	Oct 10 09:32 PM
Palihapitiya Chamath	10% Owner	Sep 19 '23	Sale	5.47	1,700,000	9,299,000	2,073,000	Sep 21 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PROK

ProKidney Corp

Upgrade your FINVIZ experience